# Progress Note 02 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Winston Churchill (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET001-SYN-TD
- Date: 1953-07-15
- Fictional facility: St. Posthumous Health Center
- Fictional author: Beatrice Okafor, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Two-week stroke review at the end of the 21-day dual antiplatelet course. **S**

## History of present illness

Mr. Churchill returns three weeks after his stroke and two weeks after his first visit, on the day after his 21-day course of aspirin with clopidogrel ended. Physical and occupational therapy began last week. His left leg is stronger and he walks indoors without the stick; his left hand is still clumsy with buttons and writing, and his speech slurs only when he is tired. His home blood pressure has been 136 to 142 over 78 to 82 on amlodipine 10 mg, without lightheadedness. He has had no new weakness, numbness, speech change, or visual symptoms, and no bleeding or bruising. He has cut down to about five cigars a day but is drinking as before. His mood is a little better, though he still becomes tearful when moved. He saw neurology this morning, and a 30-day heart monitor was fitted. **S**

| Element | Detail |
|---|---|
| Interval change | Leg stronger; walking indoors without a stick; hand still clumsy |
| Home blood pressure | 136 to 142 over 78 to 82 on amlodipine 10 mg |
| Antiplatelet therapy | Aspirin stopped yesterday after 21 days; clopidogrel continues; no bleeding |
| Tobacco and alcohol | About five cigars a day; drinking unchanged |
| Mood | Slightly better; still tearful when moved |
| Rehabilitation | Physical and occupational therapy twice weekly since last week |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tires by late afternoon |
| Neurological | Positive | Left hand clumsy; speech slurs when tired; no new weakness, numbness, or visual loss |
| Cardiovascular | Negative | No chest pain, palpitations, or lightheadedness on standing |
| Hematologic | Negative | No bruising or bleeding |
| Psychiatric | Positive | Low at times and readily tearful; sleeping poorly; no thoughts of death or self-harm |

5 systems reviewed. **S**

## Current medications

- Clopidogrel 75 mg oral tablet, one tablet by mouth daily (after a 300 mg loading dose in the hospital) **S**
- Atorvastatin 80 mg oral tablet, one tablet by mouth daily **S**
- Amlodipine 10 mg oral tablet, one tablet by mouth daily **S**
- Lisinopril 5 mg oral tablet, one tablet by mouth daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 138/80 mmHg; pulse 70 bpm; respirations 16/min; temperature 36.6 °C; oxygen saturation 96% on room air; weight 79.6 kg; BMI 28.2 kg/m². All vital signs are synthetic.

NIH Stroke Scale: 1. All results are synthetic.

## Change since baseline

- NIH Stroke Scale: 2 at baseline, 1 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Alert, articulate, and cheerful in conversation |
| Orthostatic vital signs | Seated 138/80 mmHg; standing 134/78 mmHg with no symptoms |
| Heart | Regular rhythm; no murmur |
| Neurological | NIH Stroke Scale 1 for mild left arm drift; speech clear today; mild left hand slowness on finger tapping |
| Gait | Walks without a stick with slight left circumduction |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Right-hemisphere lacunar stroke three weeks ago, improving** (I69.354). Recovering steadily. Neurology confirms a small-vessel lacunar infarct and agrees with clopidogrel alone after the 21-day course. A 30-day ambulatory ECG monitor was fitted today. **S**
   - Continue clopidogrel 75 mg daily and atorvastatin 80 mg daily.
   - Continue physical and occupational therapy.
   - Lipid panel and monitor result at the eight-week review.
2. **Essential hypertension** (I10). Blood pressure 138/80 mmHg on amlodipine 10 mg, above the 130/80 target, without orthostatic fall. **S**
   - Add lisinopril 5 mg daily.
   - Basic metabolic panel in one to two weeks.
   - Home blood pressure seated and standing.
3. **Nicotine dependence, cigars** (F17.290). Down from six to eight to about five cigars a day. **S**
   - Encouraged to keep cutting down; nicotine replacement offered and declined.
4. **Unhealthy alcohol use**. AUDIT-C 8 two weeks ago; no change in drinking. **S**
   - Brief intervention: no more than two drinks a day; alcohol raises blood pressure and the risk of another stroke and of falls.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Blood pressure seated and standing, weight and BMI | Every visit | Completed today | Seated 138/80 mmHg, standing 134/78 mmHg; weight 79.6 kg; above the 130/80 target |
| Medication safety | Short-course dual antiplatelet therapy | 21 to 90 days after a minor noncardioembolic stroke, then a single antiplatelet | Completed today | 21 days of aspirin with clopidogrel completed yesterday; clopidogrel continues alone; no bleeding |
| Medication safety | Antithrombotic and statin adherence | Every visit | Completed today | Taking clopidogrel and atorvastatin every day |
| Imaging | Prolonged cardiac rhythm monitoring | At least 30 days within 6 months of the stroke | Ordered | 30-day ambulatory ECG monitor fitted today at the neurology consultation |
| Imaging | Baseline 12-lead ECG | Once after the event | Up to date | Sinus rhythm with left ventricular hypertrophy at the first visit |
| Laboratory | Lipid panel | 4 to 12 weeks after starting or changing a statin, then every 3 to 12 months | Due | Atorvastatin started three weeks ago; due at the eight-week review |
| Laboratory | Basic metabolic panel | 1 to 2 weeks after starting an ACE inhibitor, then every 6 months | Ordered | Lisinopril started today; panel ordered for one to two weeks from now |
| Examination | NIH Stroke Scale | At presentation and with any change | Completed today | 1 (mild left arm drift), down from 2 |
| Examination | Fall-risk assessment | Every visit | Completed today | No falls; walking indoors without a stick |
| Referral | Physical and occupational therapy | At discharge and through recovery | Completed today | Twice weekly since last week |
| Referral | Neurology consultation | After the event | Completed today | Seen today |
| Survey | Depression screen (PHQ-9) | First post-stroke visit, then periodically while symptoms persist; at least yearly | Up to date | 8 at the first visit two weeks ago, item 9 scored 0; repeat at the eight-week review |
| Survey | Cognitive screen (MoCA) | After the event, again within the first year | Up to date | 26 at the first visit; repeat within the year |
| Self-management | Tobacco use | Every visit | Completed today | About five cigars a day; advice to stop; nicotine replacement declined |
| Self-management | Alcohol use | Every visit | Completed today | Drinking unchanged; brief intervention given |
| Self-management | Physical activity | Every visit | Completed today | Walking in the house and garden twice a day as therapy advises |
| Examination | Obstructive sleep apnea evaluation | Consider for all after stroke | Due | Screening questions planned at the eight-week review |

## Goal progress

- Lower blood pressure below 130/80 mmHg without orthostatic symptoms by the eight-week review. In progress; target 1953-08-19. **S**
- Lower LDL cholesterol below 70 mg/dL by the eight-week review. In progress; target 1953-08-19. **S**
- Return to full work and public speaking by about three months after the stroke. In progress; target 1953-10-07. **S**
- Keep to no more than two drinks on any day. In progress; target 1953-10-07. **S**
- Cut down to three cigars a day as a step toward stopping. In progress; target 1953-10-07. **S**

## Medication changes

- Started: Lisinopril 5 mg oral tablet, one tablet by mouth daily **S**

## Guideline basis

- 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack (2021), American Heart Association and American Stroke Association
- Primary Care of Adult Patients After Stroke: A Scientific Statement From the American Heart Association/American Stroke Association (2021), American Heart Association and American Stroke Association
- CMID: Clinical Monitoring Intelligence Database, stroke/TIA, hypertension, and depression monographs (2026), Aether Forge

## Follow-up

- Basic metabolic panel in one to two weeks. Stroke review in five weeks with a lipid panel and the monitor result. Call 911 for any new stroke symptom. **S**
- Next scheduled visit 1953-08-19: eight-week stroke and blood pressure review with lipid panel and rhythm-monitor results. **S**
